SUPPLIER PROFILE

Coriolis Pharma Research

Coriolis Pharma Research is a Contract Research Organisation (CRO) company operating in the pharmaceutical industry.

Coriolis Pharma is a globally operating contract research organization and a leader in formulation research and development of (bio)pharmaceutical drugs, including cell and gene therapy products and vaccines. Founded in 2008, Coriolis is the expert for early and late-stage biopharmaceutical development of liquid and lyophilized drug products, including lyophilization process development and analytical method development under R&D and GMP. Non-GMP manufacturing services for a wide range of products complete the service portfolio.

Company type

Contract Research Organisation (CRO)

Products and services

Contract Services – Analytical & Lab Services

Markets

Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)